Rare pulmonary diseases discussed at the Milan International Congress: facts and perspectives.
The Congress gathered together for two days most of the leading world authorities in the field of interstitial lung diseases: it was an outstanding basic and clinical update on most of the rare pulmonary diseases and orphan drugs in respiratory medicine. Here we examine the latest information outlined in the lectures and relative discussions, paying particular attention to anything of interest from a clinical point of view.